Estimate of Q4 FinancialsI have been reviewing the numbers and here is my estimate for the Q4 financials.
In Q3, the total gross revenue was $16,100 primarily broken down as follows:
Aurora - $9,678,000
Hempco - $333,000
CanvasRx - $608,000
Larsen - $2,979,000
Other - $2,502,000
In Q4, the following transactions occurred:
- CMED was completely acquired and income will include a full three months of operations
- TGOD subscription and agreement to enter into shareholder rights to get 51%
- LEAF was completely acquired, however income will be pro-rated for 10-days of the quarter. Aurora will be releasing pro-forma's to include the LEAF income. I have estimated for the 10-days.
Assuming a consistent growth of about 20-30% quarter/quarter per the review of the last few financials for each respective company my conclusion is a top line gross revenue of $29,176,630 with net income (loss) before changes in biological assets, realized & unrealized gains on marketable securities allocated and transaction-related expenses of $(13,934,000). With the acquisition costs and the changes in unrealized gains primarily on RTI and Micron Waste, I expect the net income (loss) to be about $(46,000,000).
I am taking into account elimination of intercompany estimates for Aurora, TGOD and Hempco. I am also assuming that CMED and LEAF did not generate any income from Aurora. I have also pro-rated the income inclusions based on the total income less non-controlling interest (i.e. only the amount Aurora owns or has rights to).
Accordingly, here is my allocation (before the three items mentioned earlier):
GR = Gross Revenue, NI = Net Income, NL = Net Loss
Aurora - GR of $14,702,850 with NL of $(12,586,250)
Hempco - GR of $657,110 with NL of $(607,810)
TGOD - GR of $NIL with NL of $(5,128,880)
CMED - GR of 5,781,600 and NI of $6,388,800
LEAF - GR of $1,601,870 with NL of $(109,200)
Larsen - GR of $3,574,800 with NI of $2,144,400
CanvasRx - GR of $912,000 with NL of $(1,115,000)
Other - GR of $1,946,400 with NL of $(3,006,000)
So Combined, GR of $29,176,630 and NL of $(13,934,000). I estimate that transactions costs for the quarter were about $33million (combined) bringing the net loss to the $46 million.
What do you all think? Think I'm way out to lunch or you agree?
-GLTA